Application of the new left ventricular circulation assist device iVAC 2L in high-risk percutaneous coronary intervention
10.3969/j.issn.1004-8812.2023.12.007
- VernacularTitle:新型左心室循环辅助装置iVAC 2L在高危经皮冠状动脉介入治疗中的应用
- Author:
Jian-Fang LUO
1
;
Guan-Chang TAN
;
Jun-Qing YANG
;
You-Nan YAO
;
Yu-Wei LIU
;
Jian-Ping LI
;
Yong HUO
Author Information
1. 510080 广东广州,广东省人民医院心内科广东省医学科学院广东省心血管病研究所
- Keywords:
Left ventricular circulation assist device;
Percutaneous coronary intervention
- From:
Chinese Journal of Interventional Cardiology
2023;31(12):929-934
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of the new left ventricular circulation assist device iVAC 2L in high-risk percutaneous coronaryintervention(HR-PCI)in Chinese patients.Methods We reported 6 PCIs in 5 patients supported by iVAC 2L,a new left ventricular circulation assist device,performed in Macao from September 2022 to March 2023.All patients were assessed by heart team and categorize to be high-risk for procedure.Clinical and intra-procedural data were analyzed.iVAC 2L-related complications and 30-day results were also documented.Results Insertion and removement of iVAC 2L successfully performed in all the 5 patients.Three of them underwent complete revascularization in the index procedure;one failed for the first time due to intolerance of the prolonged procedure,but succeeded for the reattempt of complete revascularization a month later,with the support of iVAC 2L.PCI was abandoned due to poor vessel condition.iVAC 2L,the new left ventricular circulation assist device,supported effectively during the 6 procedures.The patients were stable during the procedure.The success rate of hemodynamic support was 100％.No iVAC 2L-related complications and 30-day major adverse cardiac and cerebral events occurred,the 30-day survival was 100％.Conclusions Initial experience suggested that the new left ventricular circulation assist device iVAC 2L could provide effective and safe support in high-risk PCI.
